Prognosis of HER2-positive pregnancy-associated breast cancer: Analysis from the French CALG (Cancer Associ é à La Grossesse) network.
CONCLUSION: This matched case-control study implies that patients with HER2-positive BCP still have a poorer prognosis than non-pregnant HER-positive patients.
PMID: 33271423 [PubMed - as supplied by publisher]
Source: Breast - Category: Cancer & Oncology Authors: Boudy AS, Ferrier C, Selleret L, Zilberman S, Arfi A, Sussfeld J, Gligorov J, Richard S, Bendifallah S, Chabbert-Buffet N, Touboul C, Daraï E Tags: Breast Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Databases & Libraries | France Health | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pregnancy | Pregnancy and Breast Cancer | Study | Women